ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07885
0,00%
Bitcoin
61.078,88
0,47%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. BioPlus Acquisition Corporation (BIOSU)

  7. BioPlus Acquisition Corporation (BIOSU) News

BIOSU

BioPlus Acquisition (BIOSU)

BioPlus Acquisition Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BIOSU
DatumZeitQuelleÜberschriftSymbolFirma
16/10/202322h15Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:BIOSUBioPlus Acquisition Corporation
04/10/202313h39Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BIOSUBioPlus Acquisition Corporation
04/10/202313h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOSUBioPlus Acquisition Corporation
04/10/202313h30GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to LiquidateNASDAQ:BIOSUBioPlus Acquisition Corporation
15/09/202322h00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
16/08/202315h01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
14/08/202322h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIOSUBioPlus Acquisition Corporation
17/07/202314h01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
14/06/202312h09Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
14/06/202312h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
30/05/202322h04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
19/05/202322h50Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
19/05/202322h05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
15/05/202322h29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
15/05/202312h38Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:BIOSUBioPlus Acquisition Corporation
12/05/202322h17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSUBioPlus Acquisition Corporation
03/05/202314h47Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
03/05/202314h44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
27/04/202322h35Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BIOSUBioPlus Acquisition Corporation
14/02/202321h39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSUBioPlus Acquisition Corporation
02/02/202316h10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSUBioPlus Acquisition Corporation
03/11/202222h10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
11/10/202222h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
10/08/202222h33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
12/05/202222h55Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
11/03/202222h05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
09/02/202220h14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSUBioPlus Acquisition Corporation
06/12/202114h00GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSUBioPlus Acquisition Corporation
03/12/202102h55GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSUBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOSU

Kürzlich von Ihnen besucht

FX
EURJPY
Euro vs Yen
TG
BAS
BASF
TG
BAYN
Bayer
AMEX
XLE
Energy Select Sector SPDR
AMEX
XLV
Health Care Select Sector
NYSE
NKE
Nike
NASDAQ
MSFT
Microsoft
TG
432
Arbor Metals
NYSE
MCD
McDonalds
NYSE
KO
Coca Cola
USOTC
RHHBY
Roche (QX)
COIN
BTCUSD
Bitcoin
PM
XAUUSD
Gold vs US Dollar
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten